Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium therapy in amyotrophic lateral sclerosis
2009-010060-41Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Mar 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lithium in amyotrophic lateral sclerosis (ALS) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoints: Survival without complications, Survival with complications and 1 more. Started Mar 2009; status: completed.
02
Drugs
lithium
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2009-010060-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010060-41.